Acne Treatment Market Size to Reach $13.76 Billion by 2030: Consumer Buying Behavior, Rising Healthcare Expenditure, Early Approval of Skincare Drugs & Growth Pattern: The Brainy Insights

Advertisement

In recent years, acne medication or acne treatment has gained a sizable market share. The innovation and development of safer acne treatment options have led to the growth of market share in recent days. Growing consumer choice towards new organic products and low prices of acne treatment are additional factors pushing revenue growth of the market over the projection years. North America region emerged as the largest market for the global acne treatment market, with a 35.9% share of the market revenue in 2022.

Newark, Feb. 24, 2023 (GLOBE NEWSWIRE) — The brainy Insights estimates that the acne treatment market will grow from USD 9.39 billion in 2022 and reach USD 13.76 billion by 2030. Advertising and Marketing are effective in pushing global acne treatment market demand.

Get Sample PDF Brochure: https://www.thebrainyinsights.com/enquiry/sample-request/13265

Advertisement

Key Insight of Acne Treatment Market

North America to account for largest market size during the forecast period

North America is expected to have the largest market share in the acne treatment market. The United States dominate the North American acne treatment market as the region is anticipated to account for substantial revenue gain due to the country’s increased majority of acne problems and the availability of advanced acne medication options. As per the research, approximately 13% to 23% of women in North America suffer from acne at some point in their adult lives. The increased number of people suffering from acne would boost the demand for therapies and treatments. Acne impacts around 55 million people in the United States per year. Numerous major market players in the area are producing new technologies and treatments to compete with current products, while others are collaborating and acquiring with other acne therapeutics market companies.

Retinoid segment accounted for the largest market share of 26% in 2022

The product type segment is divided into antibiotics, isotretinoin, retinoids, and others. The retinoid segment dominated the market, with a market share of around 26% in 2022 due to the increasing majority of mild to severe acne, and the growing need for retinoids. For example, in February 2020, Sun Pharmaceutical Industries Ltd. declared the launch of ABSORICA LD (Isotretinoin) capsules in the United States to maintain extremely recalcitrant nodular acne in patients 13 years of age and older.

Topical segment accounted for the largest market share of 36% in 2022

The route of administration segment is divided into topical, injectable, and oral. The topical segment dominated the market, with a market share of around 36% in 2022. Topical acne treatments promote the peeling of dead skin cells to target clogged pores. They restrict the growth of bacteria that induces acne and dry-out skin due to skin shedding of dead skin cells. In addition, they inhibit the production of sebum, which decreases inflammation.

Skincare clinics segment accounted for the largest market share of 38% in 2022

The end user segment is divided into hospitals, specialty centres, and skincare clinics. The skincare clinics segment dominated the market, with a market share of around 38% in 2022. In growing countries like India, population growth has led to an expansion in acne patients, which is predicted to cause an increasing need for dermatologists and skin care clinics which are pushing market revenue growth in the segment.

For more information in the analysis of this report, speak to research analyst: https://www.thebrainyinsights.com/report/acne-treatment-market-13265

Advancement in market

In September 2021: Mayne Pharma Group Limited declared the launch of isotretinoin pills, 10 mg, 20 mg, 30 mg, and 40 mg. In the United States, isotretinoin capsules are a generic version of ABSORICA suggested for treating extreme recalcitrant nodular acne.

Market Dynamics

Drivers: The strong influence of skincare brand endorsements

Several types of makeup or skincare are heavy and oil-based, which can block skin pores and boost acne. Thus, it is advised to use non-comedogenic products. It can be challenging to see if the acne is caused by makeup or other factors. It can take a few days to 6 months for marks to appear on the skin. The delay can make it hard to see a connection between acne and the makeup or skincare products causing it.

Restraints: Side effects about current marketed medications restricting the market

Despite most of the chronic acne worldwide, specific factors restrict the acne treatment market growth. The side effect is mainly related to the medicines for acne treatment. According to the National Center for Biotechnology Information (NCBI), vomiting, nausea, or diarrhea are the most typically noticed complication of antibiotics and are marked in around 8% of total patients having tetracycline and 5% of the patients having macrolides.

Opportunity: Power of sales and marketing are creating opportunities for the market growth

Advertising and marketing are effective in pushing global acne treatment market demand. People’s increasing craze for cosmetic items is due to offline and online marketing advertising of beauty products and their uses. Acne-treating creams and lotions have also been famous over the years. The global market for acne treatment is anticipated to develop significant earnings over the projection years.

Interested to Procure The Data Inquire here at: https://www.thebrainyinsights.com/enquiry/buying-inquiry/13265

Some of the major players operating in the acne treatment market are:

• Almirall S.A.
• Bausch Health Companies Inc.
• Bayer AG
• Cutera Inc.
• Galderma Laboratories
• GlaxoSmithKline plc.
• Hoffman La Roche Ltd
• Johnson & Johnson Services Inc
• Lumenis Ltd
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Valeant Pharmaceutical International, Inc.
• Vyne Therapeutics Inc.

Key Segments cover in the market:

By Product Type:

• Antibiotics
• Isotretinoin
• Retinoids
• Others

By Route of Administration:

• Topical
• Injectable
• Oral

By End-User:

• Hospitals
• Specialty Centers
• Skincare clinics

By Region

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America)
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Direct purchase a single user copy of the report: https://www.thebrainyinsights.com/buy-now/13265/single

About the report:

The market is analysed based on value (USD Billion). All the segments have been analysed worldwide, regional, and country basis. The study includes the analysis of more than 30 countries for each part. The report analyses driving factors, opportunities, restraints, and challenges for gaining critical insight into the market. The study includes porter’s five forces model, attractiveness analysis, Product analysis, supply, and demand analysis, competitor position grid analysis, distribution, and marketing channels analysis.

About The Brainy Insights:

The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients’ objectives of high-quality output within a short span of time. We provide both customized (clients’ specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients’ requirement whether they are looking to expand or planning to launch a new product in the global market.

Contact Us

Avinash D
Head of Business Development
Phone: +1-315-215-1633
Email: [email protected] 
Web: http://www.thebrainyinsights.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.